Oncología Traslacional
ONCTRAS
Ignacio
Gil Bazo
Chercheur jusqu' 2022
Publications dans lesquelles il/elle collabore avec Ignacio Gil Bazo (29)
2024
-
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Molecular Cancer, Vol. 23, Núm. 1
2023
-
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
Frontiers in Immunology, Vol. 14
-
Biología celular del cáncer
Biología celular biomédica (Elsevier), pp. 375-407
-
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients
Journal of Translational Medicine, Vol. 21, Núm. 1
2022
-
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
Cancer Letters, Vol. 529, pp. 70-84
-
Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown
Nutrients, Vol. 14, Núm. 13
2020
-
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282
-
Id1 and pd-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-l1 expression and tumor infiltrating CD8+ T cells
Cancers, Vol. 12, Núm. 11, pp. 1-22
-
Repeated stereotactic radiosurgery for recurrent brain metastases: An effective strategy to control intracranial oligometastatic disease
Critical Reviews in Oncology/Hematology, Vol. 153
-
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Nature cancer, Vol. 1, Núm. 1, pp. 75-85
2019
-
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Thorax, Vol. 74, Núm. 4, pp. 371-379
-
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2017
-
Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer
Hospital practice (1995), Vol. 45, Núm. 3, pp. 70-75
2016
-
Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes
Brachytherapy, Vol. 15, Núm. 2, pp. 127-135
-
Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
Clinical and Translational Oncology, Vol. 18, Núm. 3, pp. 259-268
-
Successful immunotherapy against a transplantable mouse squamous lung carcinoma with anti-PD-1 and anti-CD137 monoclonal antibodies
Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. 524-536
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694
2015
-
Pneumomediastinum as a complication of SABR for lung metastases
Radiation Oncology, Vol. 10, Núm. 1
-
Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors
Minerva Chirurgica